Diwa, Baby Girl .

HRN: 27-43-94  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/18/2025
AMPICILLIN 250MG (VIAL)
07/18/2025
07/25/2025
IV
160
Q12H
1. NAMF ( Maternal UTI), 2. Live Term Neonate Delivered Cephalic Via NSVD AS 8,9 BS 39 Weeks , BW 3200grams, AGA, Thinly MSAF
Waiting Final Action 
07/18/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/18/2025
07/25/2025
IV
48
Q24H
1. NAMF ( Maternal UTI), 2. Live Term Neonate Delivered Cephalic Via NSVD AS 8,9 BS 39 Weeks , BW 3200grams, AGA, Thinly MSAF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: